Filter
6570
Filtered Results: 6570
Text search:
Centers
for
Disease
Control
and
Prevention
,
WHO
Featured
Recommendations
671
New Publications
1730
Language
Document type
No document type
3640
Studies & Reports
1022
Guidelines
948
Manuals
335
Strategic & Response Plan
253
Fact sheets
159
Training Material
87
Situation Updates
66
Resource Platforms
20
Infographics
20
Brochures
10
Online Courses
6
Dashboards/Maps
2
App
2
Countries / Regions
India
316
Global
256
Kenya
176
Sierra Leone
175
Liberia
166
Ethiopia
152
Western and Central Europe
140
Nigeria
136
Africa
129
Uganda
119
Latin America and the Carribbean
102
South Africa
100
Nepal
98
Rwanda
94
Malawi
92
Zambia
88
Tanzania
83
Congo, Democratic Republic of
73
Bangladesh
72
Syria
66
Ukraine
66
West and Central Africa
64
Ghana
63
Philippines
61
Myanmar / Burma
61
Guinea
59
Namibia
57
Middle East and North Africa
57
East and Southern Africa
55
Eastern Europe
55
Mozambique
54
Russia
49
Senegal
48
South Sudan
48
Germany
46
Zimbabwe
44
Haiti
43
South–East Asia Region
43
Asia
40
Cambodia
38
Brazil
36
Lesotho
35
Burkina Faso
32
Yemen
32
Indonesia
29
Eastern Europe and Central Asia
25
Botswana
23
Colombia
22
Madagascar
22
Mali
19
USA
19
Cameroon
19
Venezuela
19
Eswatini/ Swaziland
18
Pakistan
16
Somalia
15
Afghanistan
15
Côte d’Ivoire / Ivory Coast
14
Thailand
14
Sudan
14
Angola
14
Western Pacific Region
14
Central African Republic
12
Albania
12
Vietnam
12
Tajikistan
11
Moldova
11
Guinea-Bissau
10
Benin
10
Niger
9
Jordan
9
Lebanon
9
Argentina
9
Peru
9
Chile
9
Laos
9
Togo
8
China
8
Ecuador
8
Georgia
8
Saudi Arabia
7
Iraq
7
Chad
7
North Macedonia
7
Burundi
7
Paraguay
7
Bolivia
6
Palestine
6
Armenia
6
Spain
6
Turkey
5
Gambia
5
Papua New Guinea
5
Sri Lanka
5
Poland
5
Timor Leste/ East Timor
5
Romania
5
North America
5
Egypt
4
Hungary
4
Libya
4
Mexico
4
Kazakhstan
4
Japan
4
Honduras
3
El Salvador
3
Bhutan
3
Southern Africa
3
Canada
3
Iran
3
Gabon
3
Turkmenistan
3
France
3
Tunisia
3
United Kingdom
3
Belarus
3
Morocco
2
Malaysia
2
Mauritania
2
Greece
2
Other region
2
Congo-Brazzaville
2
Qatar
2
Bulgaria
2
Estonia
2
Slovakia
2
Uzbekistan
2
Kyrgyzstan
2
Jamaica
2
Belgium
2
Mauritius
2
Portugal
2
Ireland
1
Singapore
1
Dominican Republic
1
Austria
1
Switzerland
1
Serbia
1
Cape Verde
1
North Korea
1
Italy
1
Djibouti
1
Lithuania
1
Australia
1
Uruguay
1
Maldives
1
Morocco
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
2482
Clinical Guidelines
559
Public Health
395
Key Resources
273
Women & Child Health
245
Capacity Building
92
Pharmacy & Technologies
80
Annual Report MEDBOX
2
Toolboxes
COVID-19
816
HIV
530
TB
450
Mental Health
381
Ebola
324
Rapid Response
265
AMR
234
NTDs
176
Planetary Health
169
NCDs
155
Caregiver
150
Conflict
131
Refugee
114
Disability
94
Pharmacy
93
Zika
90
Global Health Education
87
Cholera
66
Natural Hazards
64
Health Financing Toolbox
48
Polio
44
Specific Hazards
40
Social Ethics
7
Typhoon
3
South Sudan
2
Health Financing
2
Since the World Health Organization (WHO) launched the Global Antimicrobial Resistance Surveillance System (GLASS) in 2015, there has been rapidly growing awareness among many African countries that they need to be doing more to combat an...
Mars 2020. Recommendations selon les differentes phases
Mars 2020. Recommendations selon les differentes phases
Training laboratory managers, senior biologists, and technologists in quality management systems is a step towards obtaining international recognition; it is a step that all countries should take. This training toolkit is intended to provide compreh...
COVID 19 Vaccine Perceptions: A 15 country study
recommended
Initial public health responses to control the pandemic focused on promoting protective behaviors among the general population, including frequent hand washing, physical distancing and the use of fa...
It provides selected illustrations and photographs of congenital anomalies that are severe enough to have a high probability of being captured during the first few days following birth
The goal of this course is to provide participants with the foundational skills needed to begin the development, implementation and ongoing improvement of a congenital anomalies surveillance programme, in particular ... countries with limited resources. It focuses on the methodology needed to develop either population-based or hospital based surveillance programmes.
A set of congenital anomalies will be used as examples throughout this course. The specific examples used are typically severe enough that they would probably be captured within the first few days after birth, have a significant public health impact and, for some of them, have the potential for primary prevention.
CHWs are trained public health workers who serve as a bridge between communities, health care systems, and state health departments.
Resources on this page include:
Online courses, lessons learne...
A World of Healthy People Who are Protected from Vaccine-Preventable Disease, Disability, and Death. Progress toward that vision is structured arou...
During the COVID-19 pandemic, healthcare providers in areas where dengue is endemic or who are treating patients with recent travel history to these areas, need to consider dengue and COVID-19 in th...
This guide is intended for shelter operators, planners, and staff, as well as emergency managers, public health professionals, and radiation protec...
This Cardiac Rehabilitation Change Package was completed by the Centers for Disease Control ... Prevention (CDC) in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) with the purpose of helping cardiac rehabilitation programs, hospital quality improvement teams, and public health professionals who partner with these groups to implement systems and strategies that improve care for patients who are eligible for cardiac rehabilitation. AACVPR is a multidisciplinary professional association comprised of health professionals who serve in the field of cardiac and pulmonary rehabilitation.
Epi Info™ is a public domain suite of interoperable software tools designed for the global community of public health practitioners and researchers. It provides ... easy data entry form and database construction, a customized data entry experience, and data analyses with epidemiologic statistics, maps, and graphs for public health professionals who may lack an information technology background. Epi Info™ is used for outbreak investigations; for developing small to mid-sized disease surveillance systems; as analysis, visualization, and reporting (AVR) components of larger systems; and in the continuing education in the science of epidemiology and public health analytic methods at schools of public health around the world.
The Pocket Guide to Managing Contraceptive Supplies addresses one of
the most important components of any program that provides family
planning services—the logistics system that manages the delivery,
quality, and storage of contraceptive suppl...
This document aims to help EU/EEA public health authorities in the tracing and management of persons, including healthcare workers, who had contact with COVID-19 cases. It outlines the key steps of ...
Scabies is an infestation of the skin by the human itch mite (Sarcoptes scabiei var. hominis). The microscopic scabies mite burrows into the upper layer of the skin where it lives and lays its eggs. The most common symptoms of scabies are intense it...
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like ... occurred in monkeys kept for research. The first human case was recorded in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries.
In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response.
As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa.
The Africa Centres for Disease Control and ... (Africa CDC) Biosafety and Biosecurity Initiative was launched by the Africa CDC in April 2019 with the aim of strengthening the African Union (AU) Member States’ biosafety and biosecurity systems and enabling them to comply with national and international requirements for biosafety and biosecurity including the International Health Regulations (IHR) (2005), the Biological Weapons Convention (BWC), and United Nations Security Council Resolution (UNSCR) 1540 and the multi-country Global Health Security Agenda (GHSA). The World Health Organization (WHO) Joint External Evaluation (JEE) and the Global Health Security Index report confirmed the known capacity gaps in biosafety and biosecurity among Africa Union Member (AU).
The regional consultations by Africa CDC conducted between 2019-2021 highlighted the deficiency or limited availability of standardized and regionally recognized training programs in the continent, limiting biosafety and biosecurity capacity building efforts in the region. In response, Africa CDC working with AU Member States developed a home grown, implementable and accessible professional training and certification program that is both recognized and endorsed by AU Member States. The Regional Training and Certification Program for Biosafety and Biosecurity Professionals, for African Biosafety and Biosecurity Professionals (RTCP-BBP) has four (4) areas of specialization, namely
Selection, Installation, Maintenance and Certification of Biological Safety Cabinets
Biorisk Management
Design and Maintenance of Facilities Handling High Risk Pathogens (Biocontainment Engineering)
Biological Waste management
The Africa Centres for Disease Control and ... (Africa CDC) Biosafety and Biosecurity Initiative was launched by the Africa CDC in April 2019 with the aim of strengthening the African Union (AU) Member States’ biosafety and biosecurity systems and enabling them to comply with national and international requirements for biosafety and biosecurity including the International Health Regulations (IHR) (2005), the Biological Weapons Convention (BWC), and United Nations Security Council Resolution (UNSCR) 1540 and the multi-country Global Health Security Agenda (GHSA). The World Health Organization (WHO) Joint External Evaluation (JEE) and the Global Health Security Index report confirmed the known capacity gaps in biosafety and biosecurity among Africa Union Member (AU).
The regional consultations by Africa CDC conducted between 2019-2021 highlighted the deficiency or limited availability of standardized and regionally recognized training programs in the continent, limiting biosafety and biosecurity capacity building efforts in the region. In response, Africa CDC working with AU Member States developed a home grown, implementable and accessible professional training and certification program that is both recognized and endorsed by AU Member States. The Regional Training and Certification Program for Biosafety and Biosecurity Professionals, for African Biosafety and Biosecurity Professionals (RTCP-BBP) has four (4) areas of specialization, namely
- Selection, Installation, Maintenance and Certification of Biological Safety Cabinets
- Biorisk Management
- Design and Maintenance of Facilities Handling High Risk Pathogens (Biocontainment Engineering)
- Biological Waste management
On 13 August 2024, Africa Centres for Disease Control ... Prevention (Africa CDC) declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS). This was followed the next day by the World Health Organization (WHO), which extended the alert internationally as a public health emergency of international concern (PHEIC). After these declarations, many countries have made efforts to mobilize resources to introduce or expand laboratory testing, surveillance, and response activities. In particular, as the number of suspected cases surges in the Democratic Republic of Congo (DRC), Burundi, and the Central African Republic, and an increasing number of new countries report cases, there is an urgent need to implement testing to strengthen the Mpox response. However, access to appropriate quality assured diagnostics is a challenge. There is limited information on important characteristics, such as available test kits’ performance and ability to detect relevant clades.
To address the challenge of mpox access in the continent, the Africa CDC Diagnostic Advisory Committee (DAC) met in Kigali from 19-23 August 2024 to review the available evidence on molecular tests for Mpox and to shortlist tests that may be useful for Mpox testing in countries. The shortlist aims to provide guidance to Africa CDC, countries and partners on appropriate high-quality molecular tests to procure and use for the mpox response.
